Search results
GeneDx Holdings Corp (WGS) Reports Strong Revenue Growth and Margin Expansion in Q4 2023
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Q4 2023 revenue from continuing operations increased by 27% year-over-year to $58.1...
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoGeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript April 29, 2024 GeneDx Holdings...
GeneDx Holdings Corp (WGS) Q1 2024 Earnings: Surpasses Revenue Expectations and Narrows Losses
GuruFocus.com via Yahoo Finance· 1 month agoRevenue: Reported $61.5 million from continuing operations, a 51% year-over-year increase,...
QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
Zacks via Yahoo Finance· 8 months agoQIAGEN N.V. QGEN recently announced the expansion of its clinical decision support software, QIAGEN...
Q2 2023 GeneDx Holdings Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Katherine A. Stueland; President, CEO & Director; GeneDx Holdings Corp. Kevin Feeley; Senior VP of Operations & CFO; GeneDx Holdings Corp. Tricia Truehart; Head of IR; GeneDx Holdings ...
GeneDx Holdings Corp (WGS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoGeneDx reported total revenue of $53M, marking over 40% YoY growth in exome and genome test revenue. The company expanded its gross margins to 48% in continuing operations and achieved a 52% ...
Genomic medicine offers diagnostic hope for people with rare diseases | Pediatric Research
The Columbus Dispatch via Yahoo News· 1 year agoSummer Nagele is a typical teenager — excited about school, making plans for college, and hanging...
Cholesterol-lowering gene changes may increase the risk of cataracts
NewMediaWire via Yahoo Finance· 2 years agoResearch Highlights: Researchers used large-scale genotyping and exome sequencing from more than...
Myriad Genetics (MYGN) Expands Pharma Services With New Pact
Zacks via Yahoo Finance· 7 months agoMyriad Genetics (MYGN) will market the Personalis ImmunoID NeXT ultra-comprehensive biomarker...
GeneDx Holdings Corp (WGS) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues and ...
GuruFocus.com via Yahoo Finance· 1 month agoRevenue: Q1 2024 revenue grew to $61.5 million, up 51% year-over-year from $40.7 million in Q1 2023. Gross Margin: Adjusted gross margin increased to 61% in Q1 2024 from 34% in Q1 2023. Net ...
